Financial health
- The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
3 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | — | -$9M | — | — | -269.6% | -153.4% | -$7M | — | $3M |
| 2024 | — | -$6M | — | — | -56.2% | -45.0% | -$9M | — | $10M |
| 2023 | $70069 | -$2M | 0.0% | -2563.5% | 530.4% | -57.3% | -$1M | — | $66533 |
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | — | -$3M | — | — | -78.8% | -36.1% | -$2M | — | $6M |
| Mar '26 | — | -$2M | — | — | -155.1% | -59.0% | -$2M | — | $1M |
| Dec '25 | — | -$3M | — | — | -78.2% | -44.5% | -$2M | — | $3M |
| Sep '25 | — | -$2M | — | — | -42.6% | -29.6% | -$2M | — | $5M |
| Jun '25 | — | -$2M | — | — | -32.6% | -24.4% | -$2M | — | $7M |
| Mar '25 | — | -$2M | — | — | -20.9% | -16.1% | -$1M | — | $9M |
| Dec '24 | — | -$2M | — | — | -17.6% | -14.1% | -$6M | — | $10M |
| Sep '24 | — | -$2M | — | — | 46.0% | -46.5% | -$541524 | — | $233935 |
| Jun '24 | — | -$1M | — | — | 60.1% | — | -$3M | — | — |
| Mar '24 | — | -$1M | — | — | 80.7% | — | $132391 | — | — |
| Dec '23 | -$700 | -$1M | 0.0% | 140721.0% | 285.8% | -30.9% | -$893023 | — | $66533 |
| Sep '23 | — | -$520596 | — | — | -85.7% | — | — | — | — |
| Jun '23 | — | -$178079 | — | — | -16.7% | — | — | — | — |
| Mar '23 | — | -$241150 | — | — | -20.3% | — | — | — | — |
See the revenue and net-income charts above for EXOZYMES INC.'s multi-year trend.
As of FY2025, EXOZYMES INC. reported — of total debt against $3M of cash.
In FY2025, gross margin was —, operating margin —, and net margin —.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.